SARS-CoV-2 transmission dynamics in Belarus in 2020 revealed by genomic and incidence data analysis

Abstract

Background Non-pharmaceutical interventions (NPIs) have been implemented worldwide to curb COVID-19 spread. Belarus is a rare case of a country with a relatively modern healthcare system, where highly limited NPIs have been enacted. Thus, investigation of Belarusian COVID-19 dynamics is essential for the local and global assessment of the impact of NPI strategies. Methods We integrate genomic epidemiology and surveillance methods to investigate the spread of SARS-CoV-2 in Belarus in 2020. We utilize phylodynamics, phylogeography, and probabilistic bias inference to study the virus import and export routes, the dynamics of the effective reproduction number, and the incidence of SARS-CoV-2 infection. Results Here we show that the estimated cumulative number of infections by June 2020 exceeds the confirmed case number by a factor of ~4 (95% confidence interval (2; 9)). Intra-country SARS-CoV-2 genomic diversity originates from at least 18 introductions from different regions, with a high proportion of regional transmissions. Phylodynamic analysis indicates a moderate reduction of the effective reproductive number after the introduction of limited NPIs, but its magnitude is lower than for developed countries with large-scale NPIs. On the other hand, the effective reproduction number estimate is comparable with that for the neighboring Ukraine, where NPIs were broader. Conclusions The example of Belarus demonstrates how countries with relatively low outward population mobility continue to be integral parts of the global epidemiological environment. Comparison of the effective reproduction number dynamics for Belarus and other countries reveals the effect of different NPI strategies but also emphasizes the role of regional Eastern European sociodemographic factors in the virus spread.

Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border

“…However, despite the prevalence of Omicron in New Zealand, we did not detect any infections originating from the community to the rest of the world (only from the community to the border). This contrasts with a recent study in Brazil which estimated around one export event to the rest of the world for every 10 introductions 36 , as well as studies performed in Colombia 14 , Jordan 33 , Rwanda 37 , Belarus 39 and Europe 40 . This discrepancy is perhaps due to the small population size of New Zealand at a global scale (five million people), and comparatively low global sequencing rates.…”

Excess mortality in Belarus during the COVID-19 pandemic as the case study of a country with limited non-pharmaceutical interventions and limited reporting

“…Therefore, this work fills this knowledge gap for Belarus by studying the excess overall mortality and related characteristics such as the related Google Trends search queries 28 during the epidemic period. This also complements the limited available knowledge about the Belarusian COVID-19 burden 25,29 . The limitations of such an excess mortality approach are that the exact (clinical) causes of each death are not reported for Belarus.…”

Importations of SARS-CoV-2 lineages decline after nonpharmaceutical interventions in phylogeographic analyses

“…By integrating a phylogenetic and phylogeographic analyses to infer lineage importations with a longitudinal assessment of importation dynamics, we provide an analytical framework for exploring the connections between environmental factors, such as holiday and nonpharmaceutical intervention at a population level to lineage dissemination. The effectiveness measure that we introduce allows us to systematically compare and quantify links between NPis and importations [7,11]. Through the design of this effectiveness measure, which assesses temporally local changes in the decline of lineage importations, potential longer-term effects on lineage importations, such as a seasonality, do not affect the results.…”